Lawmakers urge Biden to call out more Chinese biotech firms By Reuters
[ad_1] By Karen Freifeld (Reuters) – A Republican and a Democratic member of Congress are calling on the Biden administration to add seven Chinese biotech...
US bill on Chinese biotech firms may be more ‘narrowly tailored’, lawmaker says By Reuters
[ad_1] © Reuters. By Ben Blanchard TAIPEI (Reuters) – A bill in the U.S. Congress targeting Chinese biotech companies may end up being more “narrowly...
Wolfe Research begins coverage on biotech, names Alpine Immune Sciences as Top Pick By Investing.com
[ad_1] © Reuters. Wolfe Research begins coverage on biotech, names Alpine Immune Sciences as Top Pick Wolfe Research has initiated coverage on the biotechnology sector,...
Puma Biotech starts phase II trial for lung cancer therapy By Investing.com
[ad_1] © Reuters. LOS ANGELES – Puma Biotechnology, Inc. (NASDAQ: NASDAQ:) has commenced a Phase II clinical trial to evaluate the efficacy of its drug...
US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery By Reuters
[ad_1] 3/3 © Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29,...